President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

Jens has more than 20 years of experience in all aspects of biopharmaceutical development and manufacturing, through senior leadership roles in process & technology development, GMP manufacturing and global project leadership in the US, Germany and the UK. Prior,

Jens served as Global Head of CMC Strategy & TechRA, covering CMC development & global regulatory strategy for the entire portfolio of innovative BI biologics, biosimilars and contract development & manufacturing projects. Before joining Boehringer Ingelheim, Vogel was a Bayer’s Global Biologics Development Leadership Team member. Jens contributed to the successful licensure and post-launch support of multiple commercial biologics and more than 60 INDs/IMPDs. He was voted among the 100 most influential people in drug development and manufacture (The Medicine Maker Power List 2015). He holds a PhD in Biochemical Engineering from the University of Braunschweig, Germany and completed executive education programs at Harvard Business School, University of Notre Dame, Mendoza College of Business and Caltech.